$CAVA
CAVA Group Inc Stock $cava

$cava Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024007277 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023	2022
Revenue		$728.7M	$564.1M
YoY Change		29.17%	12.8%
Cost Of Revenue		$490.0M	$412.5M
YoY Change		18.81%	11.9%
Gross Profit		$180.3M	$151.7M
YoY Change		18.92%	15.33%
Gross Profit Margin		24.75%	26.88%
Selling, General & Admin		$101.5M	$143.0M
YoY Change		-29.04%	16.94%
% of Gross Profit		56.28%	94.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$47.43M	$42.72M
YoY Change		11.02%	-3.88%
% of Gross Profit		26.3%	28.17%
Operating Expenses		$101.5M	$185.7M
YoY Change		-45.36%	11.36%
Operating Profit		$4.725M	-$34.09M
YoY Change		-113.86%	-3.43%
Interest Expense		$8.852M	-$47.00K
YoY Change		-18934.04%	-99.02%
% of Operating Profit		187.34%
Other Income/Expense, Net		$471.0K	$919.0K
YoY Change		-48.75%	-95.47%
Pretax Income		$14.05M	-$58.89M
YoY Change		-123.85%	57.89%
Income Tax		$768.0K	$93.00K
% Of Pretax Income		5.47%
Net Earnings		$13.28M	-$58.99M
YoY Change		-122.51%	57.72%
Net Earnings / Revenue		1.82%	-10.46%
Basic Earnings Per Share		$0.22	-$44.41
Diluted Earnings Per Share		$0.21	-$0.53
COMMON SHARES
Basic Shares Outstanding	114.0M shares	60.51M shares	1.328M shares
Diluted Shares Outstanding		63.45M shares	1.328M shares

Balance Sheet

Concept	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$332.4M	$39.13M
YoY Change	749.66%	-72.11%
Cash & Equivalents	$332.4M	$39.13M
Short-Term Investments
Other Short-Term Assets	$4.962M	$6.151M
YoY Change	-19.33%	39.8%
Inventory	$5.637M	$5.139M
Prepaid Expenses
Receivables	$3.662M	$2.827M
Other Receivables	$8.223M	$4.908M
Total Short-Term Assets	$354.9M	$58.15M
YoY Change	510.34%	-62.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$620.2M	$516.9M
YoY Change	19.99%	165.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.365M	$5.548M
YoY Change	-3.3%	54.11%
Total Long-Term Assets	$628.8M	$525.7M
YoY Change	19.61%	153.0%
TOTAL ASSETS
Total Short-Term Assets	$354.9M	$58.15M
Total Long-Term Assets	$628.8M	$525.7M
Total Assets	$983.8M	$583.9M
YoY Change	68.49%	61.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.23M	$14.31M
YoY Change	20.42%	2.22%
Accrued Expenses	$87.71M	$66.74M
YoY Change	31.42%	92.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$109.0M	$84.32M
YoY Change	29.32%	63.09%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$303.8M	$285.7M
YoY Change	6.34%	1007.49%
Total Long-Term Liabilities	$303.8M	$285.7M
YoY Change	6.34%	595.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$109.0M	$84.32M
Total Long-Term Liabilities	$303.8M	$285.7M
Total Liabilities	$413.0M	$370.1M
YoY Change	11.59%	298.36%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$570.8M	$213.8M
YoY Change
Total Liabilities & Shareholders Equity	$983.8M	$583.9M
YoY Change	68.49%	61.2%

Cashflow Statement

Concept	2023	2022
OPERATING ACTIVITIES
Net Income	$13.28M	-$58.99M
YoY Change	-122.51%	57.72%
Depreciation, Depletion And Amortization	$47.43M	$42.72M
YoY Change	11.02%	-3.88%
Cash From Operating Activities	$97.10M	$6.038M
YoY Change	1508.16%	78.11%
INVESTING ACTIVITIES
Capital Expenditures	$138.8M	$104.3M
YoY Change	33.05%	84.94%
Acquisitions
YoY Change
Other Investing Activities		$162.0K
YoY Change		62.0%
Cash From Investing Activities	-$138.8M	-$104.2M
YoY Change	33.26%	84.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$3.108M	$37.00K
YoY Change	8300.0%	-99.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$335.0M	-3.084M
YoY Change	-10962.78%	-102.15%
NET CHANGE
Cash From Operating Activities	$97.10M	6.038M
Cash From Investing Activities	-$138.8M	-104.2M
Cash From Financing Activities	$335.0M	-3.084M
Net Change In Cash	$293.3M	-101.2M
YoY Change	-389.81%	-212.17%
FREE CASH FLOW
Cash From Operating Activities	$97.10M	$6.038M
Capital Expenditures	$138.8M	$104.3M
Free Cash Flow	-$41.71M	-$98.29M
YoY Change	-57.57%	85.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Restructuring Costs RestructuringCosts	6080000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	5923000	usd
CY2023	us-gaap	Pre Opening Costs PreOpeningCosts	15718000	usd
CY2022	us-gaap	Pre Opening Costs PreOpeningCosts	19313000	usd
CY2021	us-gaap	Pre Opening Costs PreOpeningCosts	8194000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-4899000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-19753000	usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-10542000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	623885000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	552824000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-52752000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001639438
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#IntangibleAssetsNetExcludingGoodwill
CY2022	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#IntangibleAssetsNetExcludingGoodwill
CY2021	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#IntangibleAssetsNetExcludingGoodwill
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	2300000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	114002237	shares
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	McLean, Virginia
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	332428000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39125000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3662000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2827000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	8223000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	4908000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5637000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5139000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4962000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6151000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	354912000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	58150000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	330730000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	242983000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	289451000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	273876000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1944000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1944000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1355000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1382000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5365000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5548000	usd
CY2023Q4	us-gaap	Assets Assets	983757000	usd
CY2022Q4	us-gaap	Assets Assets	583883000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17234000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14311000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	59219000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40468000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	32583000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29539000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	109036000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	84318000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	79000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	28000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	303615000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	285194000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	225000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	538000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	412955000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	370078000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	111874000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	95204000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	95204000	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	662308000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113708000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113708000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1409000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1409000	shares
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	11000	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1086000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	886000	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	9727000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	6619000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1028181000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19059000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-447663000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-460943000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	570802000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-448503000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	983757000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	583883000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	728700000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	564119000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	500072000	usd
CY2023	us-gaap	Cost Direct Material CostDirectMaterial	213458000	usd
CY2022	us-gaap	Cost Direct Material CostDirectMaterial	179988000	usd
CY2021	us-gaap	Cost Direct Material CostDirectMaterial	154772000	usd
CY2023	us-gaap	Cost Direct Labor CostDirectLabor	187326000	usd
CY2022	us-gaap	Cost Direct Labor CostDirectLabor	157891000	usd
CY2021	us-gaap	Cost Direct Labor CostDirectLabor	143395000	usd
CY2023	us-gaap	Occupancy Net OccupancyNet	58319000	usd
CY2022	us-gaap	Occupancy Net OccupancyNet	53669000	usd
CY2021	us-gaap	Occupancy Net OccupancyNet	49299000	usd
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	89251000	usd
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	74587000	usd
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	70453000	usd
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	548354000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	466135000	usd
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	417919000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	101491000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70037000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	64792000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47433000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42724000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44538000	usd
CY2021	us-gaap	Restructuring Costs RestructuringCosts	6839000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	723975000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	4725000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-59766000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8852000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-47000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4810000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	471000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	919000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20288000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14048000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58894000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37274000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	768000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58987000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-37391000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-51.06
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63448000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	80086000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	478941000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-360428000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5351000	usd
CY2021	cava	Adjustments To Additional Paid In Capital Shares Purchased Under Equity Plan AdjustmentsToAdditionalPaidInCapitalSharesPurchasedUnderEquityPlan	7135000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	260000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	7900000	usd
CY2021	cava	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	16901000	shares
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	204068000	usd
CY2021	cava	Temporary Equity Shares Redemption TemporaryEquitySharesRedemption	1783000	shares
CY2021	cava	Temporary Equity Value Redemption TemporaryEquityValueRedemption	20701000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7428000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-37391000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	95204000	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	662308000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-393021000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3803000	usd
CY2022	cava	Adjustments To Additional Paid In Capital Shares Purchased Under Equity Plan AdjustmentsToAdditionalPaidInCapitalSharesPurchasedUnderEquityPlan	37000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	911000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58987000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	95204000	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	662308000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-448503000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9360000	usd
CY2023	cava	Adjustments To Additional Paid In Capital Shares Purchased Under Equity Plan AdjustmentsToAdditionalPaidInCapitalSharesPurchasedUnderEquityPlan	1353000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3108000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	29300000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	336111000	usd
CY2023	cava	Temporary Equity Shares Conversion Of Convertible Securities TemporaryEquitySharesConversionOfConvertibleSecurities	95204000	shares
CY2023	cava	Temporary Equity Value Conversion Of Convertible Securities TemporaryEquityValueConversionOfConvertibleSecurities	662308000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	662309000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	13280000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	570802000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	13280000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58987000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-37391000	usd
CY2023	us-gaap	Depreciation Depreciation	47406000	usd
CY2022	us-gaap	Depreciation Depreciation	37086000	usd
CY2021	us-gaap	Depreciation Depreciation	38269000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5638000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6176000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	9360000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3803000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5351000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-4899000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-19753000	usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-10542000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	20000000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	835000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	50000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-453000	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	3315000	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1626000	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1356000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	498000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1496000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1157000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-60000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	318000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1402000	usd
CY2023	cava	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	20521000	usd
CY2022	cava	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	34187000	usd
CY2021	cava	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2549000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	336000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-555000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	19173000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2901000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1172000	usd
CY2021	cava	Increase Decrease In Deferred Rent Credit IncreaseDecreaseInDeferredRentCredit	3291000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	25516000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	38987000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	97101000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6038000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3393000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	138806000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104161000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56309000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-138806000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104161000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56309000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	7900000	usd
CY2023	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	204068000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	6000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	6000000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40000000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3108000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	911000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7688000	usd
CY2023	cava	Proceeds From Shares Purchased Under Equity Plan ProceedsFromSharesPurchasedUnderEquityPlan	1353000	usd
CY2022	cava	Proceeds From Shares Purchased Under Equity Plan ProceedsFromSharesPurchasedUnderEquityPlan	37000	usd
CY2021	cava	Proceeds From Shares Purchased Under Equity Plan ProceedsFromSharesPurchasedUnderEquityPlan	7135000	usd
CY2021	cava	Underwriting Discounts And Commissions UnderwritingDiscountsAndCommissions	22800000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	342604000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5384000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1109000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	372000	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	986000	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2023	cava	Proceeds From Payments For Landlord Financing Net ProceedsFromPaymentsForLandlordFinancingNet	85000	usd
CY2022	cava	Proceeds From Payments For Landlord Financing Net ProceedsFromPaymentsForLandlordFinancingNet	115000	usd
CY2021	cava	Proceeds From Payments For Landlord Financing Net ProceedsFromPaymentsForLandlordFinancingNet	-338000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	335008000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3084000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	143152000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	293303000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-101207000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	90236000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39125000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140332000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50096000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	332428000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39125000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140332000	usd
CY2023	cava	Deferred Offering Costs Accrued Not Yet Paid DeferredOfferingCostsAccruedNotYetPaid	0	usd
CY2022	cava	Deferred Offering Costs Accrued Not Yet Paid DeferredOfferingCostsAccruedNotYetPaid	542000	usd
CY2021	cava	Deferred Offering Costs Accrued Not Yet Paid DeferredOfferingCostsAccruedNotYetPaid	0	usd
CY2023	cava	Interest Paid Landlord Financing InterestPaidLandlordFinancing	0	usd
CY2022	cava	Interest Paid Landlord Financing InterestPaidLandlordFinancing	0	usd
CY2021	cava	Interest Paid Landlord Financing InterestPaidLandlordFinancing	4023000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	330000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	161000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	768000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	116000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	523000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	212000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	584000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5083000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1770000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	662309000	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2023Q4	us-gaap	Number Of Restaurants NumberOfRestaurants	309	restaurant
CY2023Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	24	state
CY2023Q4	cava	Number Of Restaurants Excluded From Restaurant Count NumberOfRestaurantsExcludedFromRestaurantCount	2	restaurant
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q4	cava	Number Of Conversion Restaurants Opened NumberOfConversionRestaurantsOpened	153	restaurant
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification</span>—Certain prior year amounts have been reclassified to conform to current year presentation.
CY2023	us-gaap	Fiscal Period FiscalPeriod	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year</span>—The Company operates on a 52-week or 53-week fiscal year that ends on the last Sunday of the calendar year. The fiscal year ended December 31, 2023 (“fiscal 2023”) includes 53 weeks and the fiscal years ended December 25, 2022 (“fiscal 2022”) and December 26, 2021 (“fiscal 2021”) each include 52 weeks. In a 52-week fiscal year, the first fiscal quarter contains sixteen weeks and the second, third, and fourth fiscal quarters each contain twelve weeks. In a 53-week fiscal year, the first fiscal quarter contains sixteen weeks, the second and third fiscal quarters each contain twelve weeks, and the fourth fiscal quarter contains thirteen weeks.
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span>—The accompanying consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include the valuation allowance on deferred tax assets, equity-based compensation, lease accounting matters, impairment of long-lived assets including right-of-use assets, and legal liabilities. These estimates are based on information available as of the date of the consolidated financial statements; therefore actual results could differ from those estimates.
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	200000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1900000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1300000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	9000000	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	3200000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23370000	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6100000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	7100000	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	7200000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1700000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	728700000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	564119000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	500072000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1000000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	600000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	700000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	472745000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	356375000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	142015000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	113392000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	330730000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	242983000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1292000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8976000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3225000	usd
CY2023	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-3607000	usd
CY2022	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-10777000	usd
CY2021	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-7317000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-4899000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-19753000	usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-10542000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1900000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1355000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1355000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1355000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1355000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1355000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1355000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2562000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1180000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1382000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13413000	usd
CY2023Q4	cava	Accrued Capital Purchases Current AccruedCapitalPurchasesCurrent	7935000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1000	usd
CY2022Q4	cava	Accrued Capital Purchases Current AccruedCapitalPurchasesCurrent	7726000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3807000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2339000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4096000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3271000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20011000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13719000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	59219000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40468000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	95204000	shares
CY2023Q4	cava	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOutstandingNumber	5731000	shares
CY2022Q4	cava	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOutstandingNumber	3639000	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	14778000	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	100516000	shares
CY2023Q2	cava	Temporary Equity Shares Conversion Of Convertible Securities TemporaryEquitySharesConversionOfConvertibleSecurities	95200000	shares
CY2023Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q2	cava	Temporary Equity Conversion Ratio TemporaryEquityConversionRatio	1
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	111874000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	95204000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	95204000	shares
CY2022Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	723065000	usd
CY2022Q4	cava	Temporary Equity Carrying Amount Attributable To Parent Net TemporaryEquityCarryingAmountAttributableToParentNet	662308000	usd
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	88400000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	718000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	88000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	114000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	718000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	88000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	114000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	20000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	30000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	50000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	768000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2950000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12323000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-7846000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	996000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1885000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3231000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-4699000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	13428000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	15795000	usd
CY2023	cava	Effective Income Tax Rate Reconciliation Deferred Taxes Amount EffectiveIncomeTaxRateReconciliationDeferredTaxesAmount	1032000	usd
CY2022	cava	Effective Income Tax Rate Reconciliation Deferred Taxes Amount EffectiveIncomeTaxRateReconciliationDeferredTaxesAmount	1318000	usd
CY2021	cava	Effective Income Tax Rate Reconciliation Deferred Taxes Amount EffectiveIncomeTaxRateReconciliationDeferredTaxesAmount	572000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-556000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-541000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-994000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	915000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	usd
CY2023	cava	Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount EffectiveIncomeTaxRateReconciliationPPPLoanForgivenessAmount	0	usd
CY2022	cava	Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount EffectiveIncomeTaxRateReconciliationPPPLoanForgivenessAmount	0	usd
CY2021	cava	Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount EffectiveIncomeTaxRateReconciliationPPPLoanForgivenessAmount	4200000	usd
CY2023	cava	Effective Income Tax Rate Reconciliation Other Permanent M1 Adjustments Amount EffectiveIncomeTaxRateReconciliationOtherPermanentM1AdjustmentsAmount	-130000	usd
CY2022	cava	Effective Income Tax Rate Reconciliation Other Permanent M1 Adjustments Amount EffectiveIncomeTaxRateReconciliationOtherPermanentM1AdjustmentsAmount	-96000	usd
CY2021	cava	Effective Income Tax Rate Reconciliation Other Permanent M1 Adjustments Amount EffectiveIncomeTaxRateReconciliationOtherPermanentM1AdjustmentsAmount	-21000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	768000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	59012000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	65423000	usd
CY2023Q4	cava	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	89700000	usd
CY2022Q4	cava	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	81204000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	4692000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5230000	usd
CY2023Q4	cava	Deferred Tax Assets Interest Expense DeferredTaxAssetsInterestExpense	0	usd
CY2022Q4	cava	Deferred Tax Assets Interest Expense DeferredTaxAssetsInterestExpense	1602000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1596000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2161000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5732000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3293000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	160732000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	158913000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83662000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	88361000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	77070000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	70552000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	77149000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	70580000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	77149000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	70580000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	79000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	28000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	222200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	224100000	usd
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	7700000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0601
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0551
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	44201000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	42551000	usd
CY2023	cava	Pre Opening Lease Costs PreOpeningLeaseCosts	4296000	usd
CY2022	cava	Pre Opening Lease Costs PreOpeningLeaseCosts	3823000	usd
CY2023	cava	Closed Store Lease Cost ClosedStoreLeaseCost	558000	usd
CY2022	cava	Closed Store Lease Cost ClosedStoreLeaseCost	840000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	364000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	460000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1421000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	327000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	479000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	659000	usd
CY2023	us-gaap	Lease Cost LeaseCost	50361000	usd
CY2022	us-gaap	Lease Cost LeaseCost	47342000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	48739000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	49984000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	43985000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	322015000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	4946000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	17041000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	51572000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	56121000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	55186000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	52959000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	47980000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	171699000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	435517000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	99319000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	336198000	usd
CY2023Q4	cava	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	97600000	usd
CY2023Q4	cava	Number Of Irrevocable Letters Of Credit NumberOfIrrevocableLettersOfCredit	4	letters_of_credit
CY2022Q4	cava	Number Of Irrevocable Letters Of Credit NumberOfIrrevocableLettersOfCredit	8	letters_of_credit
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	500072000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1432000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.45
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3828000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	459000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.75
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	15000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.42
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	13000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.73
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1863000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.04
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8444000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1373000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	19.61
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	79000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.34
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	79000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.47
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3078000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.45
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	97054000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1441000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.71
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3078000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.45
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	97054000	usd
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	548354000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	466135000	usd
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	417919000	usd
CY2023	us-gaap	Gross Profit GrossProfit	180346000	usd
CY2022	us-gaap	Gross Profit GrossProfit	97984000	usd
CY2021	us-gaap	Gross Profit GrossProfit	82153000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	101491000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	70037000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	64792000	usd
CY2023	cava	Employee Stock Purchase Plan Offering Period EmployeeStockPurchasePlanOfferingPeriod	P6M
CY2023	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	100000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	13280000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58987000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-37391000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60512000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1328000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	732000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2936000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63448000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1328000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	732000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-44.41
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-51.06
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-44.41
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-51.06
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	98181000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	97461000	shares
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	728700000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	564119000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	47433000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42724000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44538000	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	6080000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	5923000	usd
CY2021	us-gaap	Restructuring Costs RestructuringCosts	6839000	usd
CY2023	us-gaap	Pre Opening Costs PreOpeningCosts	15718000	usd
CY2022	us-gaap	Pre Opening Costs PreOpeningCosts	19313000	usd
CY2021	us-gaap	Pre Opening Costs PreOpeningCosts	8194000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-4899000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-19753000	usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-10542000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8852000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-47000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4810000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	471000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	919000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20288000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14048000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58894000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37274000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-007277-index-headers.html	Edgar Link	pending
0001628280-24-007277-index.html	Edgar Link	pending
0001628280-24-007277.txt	Edgar Link	pending
0001628280-24-007277-xbrl.zip	Edgar Link	pending
cava-20231231.htm	Edgar Link	pending
cava-20231231.xsd	Edgar Link	pending
cava-20231231_g1.jpg	Edgar Link	pending
ex211subsidiariesofthecomp.htm	Edgar Link	pending
ex231consentofdeloittetouc.htm	Edgar Link	pending
ex3112023q4.htm	Edgar Link	pending
ex3122023q4.htm	Edgar Link	pending
ex3212023q4.htm	Edgar Link	pending
ex3222023q4.htm	Edgar Link	pending
ex41descriptionofsecurities.htm	Edgar Link	pending
ex971cavagroupincincentive.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
cava-20231231_cal.xml	Edgar Link	unprocessable
cava-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cava-20231231_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cava-20231231_lab.xml	Edgar Link	unprocessable
cava-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAVA
CAVA Group Inc Stock $cava

2024 Q1 Form 10-K Financial Statement

#000162828024007277 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAVA CAVA Group Inc Stock $cava

2024 Q1 Form 10-K Financial Statement

#000162828024007277 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAVA
CAVA Group Inc Stock $cava